CJC-1295 / Ipamorelin vs KLOW
CJC-1295 / Ipamorelin and KLOW come from different research areas and are studied in largely separate models — researchers usually compare them when scoping a broader protocol.
✓ both US-made · third-party tested · batch COA on every order
Last updated August 25, 2026
How do CJC-1295 / Ipamorelin and KLOW differ?
CJC-1295 / Ipamorelin (Co-formulated GHRH-analog and secretagogue blend) is catalogued under longevity & cellular research; KLOW (Four-peptide research blend · cellular research) is catalogued under recovery & gut research. Verve lists 5 reported research applications for CJC-1295 / Ipamorelin and 4 for KLOW. Both are made in the United States, screened by HPLC to a 99%+ purity standard, and shipped with a batch-level certificate of analysis.
| field | CJC-1295 / Ipamorelin | KLOW |
|---|---|---|
| compound class | Co-formulated GHRH-analog and secretagogue blend | Four-peptide research blend · cellular research |
| research area | longevity & cellular | recovery & gut |
| reported research applications | 5 listed | 4 listed |
| supplied as | co-formulated blend | co-formulated blend |
| catalog sizes | 10mg | 80mg · 160mg |
| purity standard | 99%+ by HPLC | 99%+ by HPLC |
| manufactured | United States | United States |
| batch COA | published per lot | published per lot |
| endotoxin-tested option | available | available |
| co-formulated together in | not co-formulated | not co-formulated |
| price from | $157.49 | $185.99 |
| availability | in stock | in stock |
Prices and stock read live from the catalog. Both compounds are supplied strictly as reference materials for in-vitro laboratory research.
What is CJC-1295 / Ipamorelin and what is KLOW?
CJC-1295 / Ipamorelin is classified as Co-formulated GHRH-analog and secretagogue blend; KLOW as Four-peptide research blend · cellular research. Both profiles below cover scientific identity only — what the molecule is and which laboratory models it appears in. Verve supplies both strictly as in-vitro reference materials, and neither profile describes human or veterinary use.
CJC-1295 / Ipamorelin
Co-formulated GHRH-analog and secretagogue blend
CJC-1295 / Ipamorelin is a co-formulated research blend of two peptides that act at separate receptors. CJC-1295 without DAC, also referred to as Mod GRF 1-29, is a modified 29-amino-acid analog of growth-hormone-releasing hormone characterized as a GHRH-receptor agonist. Ipamorelin is a synthetic pentapeptide characterized as a selective agonist at the growth-hormone secretagogue receptor, GHS-R1a.
full CJC-1295 / Ipamorelin profile →KLOW
Four-peptide research blend · cellular research
KLOW is a research blend that combines four of the most-studied peptides (BPC-157, TB-500, GHK-Cu, and KPV) in a single vial. Verve supplies it as a high-purity, batch-tested research preparation for cellular research.
full KLOW profile →Which research models is each compound studied in?
CJC-1295 / Ipamorelin sits in longevity & cellular research and KLOW in recovery & gut research, so their listed models largely do not intersect. The table lists 5 reported research applications for CJC-1295 / Ipamorelin and 4 for KLOW. Rows are per compound, not equivalences.
| CJC-1295 / Ipamorelin — reported research applications | KLOW — reported research applications |
|---|---|
| Dual-pathway GHRH-receptor and GHS-R1a signaling research | Multi-compound cellular research |
| Receptor cross-talk and signal-transduction research models | Tissue-repair research models |
| Comparative agonist research versus single-component preparations | Extracellular-matrix and remodeling research |
| Endocrine-signaling research in cellular and pre-clinical models | Comparative peptide research |
| Peptide stability and analog structure–activity research | — |
Research contexts only. Both compounds are supplied for laboratory research use only, and no entry above describes an effect in humans or animals.
What sizes and prices does verve list for CJC-1295 / Ipamorelin and KLOW?
CJC-1295 / Ipamorelin is listed from $157.49 and KLOW from $185.99. The table below is every catalog size verve currently lists for the two compounds, at single-vial prices before the automatic multi-compound discount. Sizes describe the vial format supplied to the laboratory, nothing more.
| compound | size listed | price | availability |
|---|---|---|---|
| CJC-1295 / Ipamorelin | 10mg | $157.49 | in stock |
| KLOW | 80mg | $185.99 | in stock |
| KLOW | 160mg | $314.49 | in stock |
Any 2 different compounds take 20% off, any 3 take 30% — applied automatically in the cart, no code. Orders placed Monday–Friday ship by 2pm CT, free over $100.
shop the compounds →Frequently asked questions about CJC-1295 / Ipamorelin and KLOW
What is CJC-1295 / Ipamorelin?
It is a co-formulated research blend of CJC-1295 without DAC (also called Mod GRF 1-29), a GHRH analog, and ipamorelin, a selective GHS-R1a agonist. Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.
What is the difference between CJC-1295 with and without DAC?
The DAC (drug affinity complex) modification is a chemical addition studied for its effect on the analog's circulating half-life in pre-clinical models. The no-DAC form, Mod GRF 1-29, lacks that modification and is the component used in this blend.
What is KLOW?
KLOW is a research blend of four peptides (BPC-157, TB-500, GHK-Cu, and KPV) in one vial. Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.
What is KLOW studied for in research?
It is used in multi-compound cellular and tissue-repair research models where these four peptides are studied together. Verve makes no health claims.
related comparisons
verve products are sold for laboratory research and development purposes only and are not intended for human or veterinary use of any kind. statements on this site have not been evaluated by the FDA.